American Society of Clinical Oncology: e-Learning Courses: Genetics and Genomics for the Practicing Clinician

This seminar covers tumor and germ line topics, as well as explains the variety of tests available to the clinician and when they should be administered. Learning Objectives:

Upon participation in this activity, attendees will be able to:

  • Evaluate a range of genetic and genomic technologies
  • Discuss how to use genomic targets to choose appropriate therapies
  • Effectively address the issues to be considered in the evaluation of germline and somatic genetics
  • Share the power of genetics and genomics with their practices for the benefit of patients and their families

Type Course
CME Available Yes
Cost $60
Note To many specific competencies are covered in the content, so just the major areas are selected.
Date of Resource 2013

Genomic Competencies

Experts from the disciplines listed below have tagged this resource as fulfulling genomic competencies.


  • Family History
    • P-FH1H:   Personal and Professional Development
      • 1H2:   Maintain continuing medical education on matters of medical genetics
  • Genomic Testing
    • P-GT2A:   Patient Care
      • 2A1:   Discuss the indications for genomic testing - specifically the benefits, risks, and alternatives
      • 2A4:   Discuss risks of having genomic testing done: e.g., psychological implications for the individual as well as the family; the potential for discrimination; and the potential effect on insurance coverage.
      • 2A6:   Order, interpret, and communicate the results of appropriate genomic tests, within the physician’s scope of practice
    • P-GT2B:   Knowledge for Practice
      • 2B3:   Recognize that genomic tests require interpretation with respect to the patient’s clinical status (e.g., pathogenic, likely pathogenic, benign)
    • P-GT2C:   Practice-Based Learning and Improvement
      • 2C1:   Incorporate genomic findings into the health record and patient-care plan
    • P-GT2D:   Interpersonal and Communication Skills
      • 2D4:   Address the needs of the patient as an individual as well as the needs of family members
    • P-GT2H:   Personal and Professional Development
      • 2H1:   Engage in continuing education regarding advances in genomic medicine and changing indications for and interpretation of genomic testing
  • Patient Treatment Based on Genomic Results
    • P-PM3A:   Patient Care
      • 3A3:   Discern the potential clinical impact of genetic variation on risk stratification and individualized treatment
    • P-PM3B:   Knowledge for Practice
      • 3B3:   Recognize that genomic test results may guide choice of therapy for multifactorial disorders
      • 3B4:   Recognize that there is variability in the phenotypic expression of genetic variants and in response to therapy
      • 3B5:   Recognize that the effects of some medications are strongly influenced by inherited or somatically acquired genetic variation
    • P-PM3D:   Interpersonal and Communication Skills
      • 3D1:   Discuss benefits, risks, and alternatives of various preventive and therapeutic approaches driven by genomic findings
    • P-PM3H:   Personal and Professional Development
      • 3H1:   Maintain the medical knowledge and clinical competence in genomics required for the provision of therapy
  • Somatic Genomics
    • P-SG4A:   Patient Care
      • 4A1:   Identify or facilitate identification of patients who may benefit from genomic testing of tissue
      • 4A2:   Explain the benefits and limitations of somatic genomic testing to the patient, including implications regarding treatment of their condition and clarification of his/her prognosis
    • P-SG4D:   Interpersonal and Communication Skills
      • 4D3:   Ensure that specialists involved in a patients care are communicating with one another and with the patient
      • 4D4:   Communicate to patients potential implications for his/her family
    • P-SG4H:   Personal and Professional Development
      • 4H1:   Keep up-to-date with progress in the diagnosis and treatment of cancer and other tissue-based disorders